Solifenacin Succinate Tablets IP 5 Mg – Kelvoria 5 Tablets

Kelvoria 5 Tablets
Composition:- Solifenacin Succinate Tablets IP 5 Mg

Kelvoria 5 Tablets contains Solifenacin Succinate Tablets IP 5 mg, a selective M3 muscarinic receptor antagonist used to treat overactive bladder (OAB). It works by relaxing the detrusor muscle of the bladder, reducing involuntary contractions. This helps control urgency, frequent urination, and urge incontinence, improving the patient’s quality of life with a simple once-daily dosing regimen.

Marketed by: Wonne International Pvt. Ltd.

Key points of Solifenacin Succinate Tablets IP 5 Mg – Kelvoria 5 Tablets

• Selective bladder action  — Targets M3 receptors in the bladder, relaxing the detrusor muscle and reducing overactive contractions.
• Relieves all three OAB symptoms  — Reduces urgency, urinary frequency, and urge urinary incontinence effectively.
• Favourable tolerability: Bladder-selective profile means fewer systemic anticholinergic side effects; dry mouth and constipation are the most common, usually mild.

Can be Prescribed by:

• Urology
• Gynaecology
• General Practice
• Geriatrics
• Internal Medicine

Disclaimer: To be used under medical supervision only and not intended for general public promotion. This content is meant for registered healthcare professionals only.